Understanding eosinophilic disorders and their mechanisms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the mechanisms of eosinophil growth, survival, migration, and function in patients with eosinophilic gastrointestinal disease, eosinophilic inflammatory disease, or food allergies. By collecting data and samples, the study seeks to characterize the pathophysiology and clinical manifestations of eosinophilic inflammation in humans. The research will involve patients diagnosed with these conditions as well as normal controls and family members. The findings could provide insights into the severity spectrum of these diseases.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Signed informed consent obtained from the patient or parent/guardian. Assent will be obtained from all minors 11 years of age and older.
* Carrying a diagnosis of eosinophilic gastrointestinal disease, eosinophilic inflammatory disease, or food allergy OR family member, or normal control

Where it's running

• Cincinnati Children's Hospital Medical Center
  Cincinnati, Ohio, United States Recruiting

Study contacts

• Principal investigator: Marc E. Rothenberg, M.D., Ph.D. — Cincinnati Children's Hospital Medical Center
• Study coordinator: Bliss Magella
• Email: bliss.magella@cchmc.org
• Phone: 513-636-7832

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oral Food Challenge After Starting Omalizumab in Food Allergy

  This trial tests whether omalizumab begins to help with food allergy within 2 to 4 weeks after starting treatment in people with a confirmed food allergy.

  Recruiting Phase 4 Johns Hopkins University · Baltimore, Maryland · NCT07845552

• Early Introduction of Allergenic Foods in Infants With Extra Support

  This study tests whether giving families educational materials alone or with extra in-person or live-stream support helps parents introduce known allergenic foods to their infants earlier.

  Recruiting Stanford University · Stanford, California · NCT07321522

• EmoTIChealth: a serious game to strengthen emotional skills in teens with and without chronic conditions

  This project will try a digital serious game for 12–16-year-olds to boost socioemotional skills and offer tailored support for teens with asthma, food allergy, type 1 diabetes, or allergic rhinitis.

  Recruiting University of Valencia · Valencia, Valencia · NCT07212530

• Omalizumab given by weight for food allergy

  This study will test whether higher, weight-based doses of omalizumab are safe and help people with food allergies, including those with very high allergic antibody (IgE) levels, tolerate their allergens better.

  Recruiting at 3 sites Phase 2 Massachusetts General Hospital · Boston, Massachusetts and 2 other locations · NCT06943534

• Effect of food sample shelf life on prick-to-prick test reproducibility

  We will test whether prick-to-prick skin tests with fresh versus stored (frozen or dried) native foods give the same results in adults with confirmed food allergies.

  Recruiting Centre Hospitalier Régional d'Orléans · Orléans · NCT06872996

• Assessing milk ladders for children with cow's milk protein allergy

  This study is testing two different milk ladder plans to see which one helps young children with a cow's milk allergy tolerate milk better.

  Recruiting Medical University of Warsaw · Warsaw and 1 other locations · NCT06664918

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.